Search
for
Sort by
Research 331–360 of 1000+
- Behcet's disease and complex aphthosis
- Cutaneous mycoses in the elderly
- The effects of extra cellular matrix and growth factors on dermal papilla cell proliferation
- Cutaneous signals of immune system disease
- Panel discussion: The efficacy of retinoids in the treatment of psoriasis
- NEW ENGLAND DERMATOLOGICAL SOCIETY
- Potential Herbal Medicine for Alopecia Areata Treatment : A Systematic Review
- The role of lymphocytes in the development and treatment of alopecia areata
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Oral Lichen Planus
- Acquired scalp alopecia. Part II: A review
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Alopecia Areata
- Alopecia areata: Part 2: treatment.
- Vitiligo: an evidence-based update. Report of the 13th Evidence Based Update Meeting, 23 May 2013, Loughborough, U.K.
- TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Valproate-acid-induced cutaneous leukocytoclastic vasculitis.
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- LUPUS ERYTHEMATOSUS AND THE SKIN
- Scarring Alopecia in Pediatric Patients: A Narrative Review of Etiologies, Diagnosis, and Management Strategies
- Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
- A Case Study on Exploring Immune Dysregulation in Alopecia Areata - Mechanisms and Treatments Outcomes
- A Case Report On Alopecia Areata – A Comprehensive Clinical Analysis
- Baricitinib (Olumiant)
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- A patient with diffuse hair loss
- Cutaneous Toxicities From Transplantation-Related Medications
- 563 CsA-induced hypertrichosis might be caused in part by inhibition of TGF-β2 expression in dermal papilla cells.